These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17187586)

  • 1. Pharmacodynamic effects of a novel prokinetic 5-HT receptor agonist, ATI-7505, in humans.
    Camilleri M; Vazquez-Roque MI; Burton D; Ford T; McKinzie S; Zinsmeister AR; Druzgala P
    Neurogastroenterol Motil; 2007 Jan; 19(1):30-8. PubMed ID: 17187586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of 5-hydroxytryptamine4-receptor agonist, YKP10811, on colonic transit and bowel function in functional constipation.
    Shin A; Acosta A; Camilleri M; Boldingh A; Burton D; Ryks M; Rhoten D; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):701-8.e1. PubMed ID: 25148765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
    Andresen V; Camilleri M; Busciglio IA; Grudell A; Burton D; McKinzie S; Foxx-Orenstein A; Kurtz CB; Sharma V; Johnston JM; Currie MG; Zinsmeister AR
    Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of daikenchuto (TU-100) on gastrointestinal and colonic transit in humans.
    Manabe N; Camilleri M; Rao A; Wong BS; Burton D; Busciglio I; Zinsmeister AR; Haruma K
    Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G970-5. PubMed ID: 20378829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans.
    Bouras EP; Camilleri M; Burton DD; McKinzie S
    Gut; 1999 May; 44(5):682-6. PubMed ID: 10205205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relamorelin Relieves Constipation and Accelerates Colonic Transit in a Phase 2, Placebo-Controlled, Randomized Trial.
    Acosta A; Camilleri M; Kolar G; Iturrino J; Szarka LA; Boldingh A; Burton D; Ryks M; Rhoten D; Zinsmeister AR; Spence SC; Gottesdiener K; Bouras EP; Vazquez-Roque MI
    Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2312-9.e1. PubMed ID: 26001337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome.
    Camilleri M; Vazquez-Roque M; Iturrino J; Boldingh A; Burton D; McKinzie S; Wong BS; Rao AS; Kenny E; Månsson M; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(1):G120-8. PubMed ID: 22517769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation.
    Manini ML; Camilleri M; Goldberg M; Sweetser S; McKinzie S; Burton D; Wong S; Kitt MM; Li YP; Zinsmeister AR
    Neurogastroenterol Motil; 2010 Jan; 22(1):42-9, e7-8. PubMed ID: 19691492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of selective and non-selective muscarinic antagonists on gastrointestinal transit and bowel function in healthy women.
    Bharucha AE; Isowa H; Hiro S; Guan Z
    Neurogastroenterol Motil; 2013 Jan; 25(1):e35-43. PubMed ID: 23171069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects.
    Degen L; Matzinger D; Merz M; Appel-Dingemanse S; Osborne S; Lüchinger S; Bertold R; Maecke H; Beglinger C
    Aliment Pharmacol Ther; 2001 Nov; 15(11):1745-51. PubMed ID: 11683688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tolterodine on gastrointestinal transit and bowel habits in healthy subjects.
    Bharucha AE; Seide B; Guan Z; Andrews CN; Zinsmeister AR
    Neurogastroenterol Motil; 2008 Jun; 20(6):643-8. PubMed ID: 18312543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?
    Sweetser S; Camilleri M; Linker Nord SJ; Burton DD; Castenada L; Croop R; Tong G; Dockens R; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1299-306. PubMed ID: 19342506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome.
    Prather CM; Camilleri M; Zinsmeister AR; McKinzie S; Thomforde G
    Gastroenterology; 2000 Mar; 118(3):463-8. PubMed ID: 10702196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study.
    Esfandyari T; Camilleri M; Ferber I; Burton D; Baxter K; Zinsmeister AR
    Neurogastroenterol Motil; 2006 Sep; 18(9):831-8. PubMed ID: 16918762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of atilmotin on gastrointestinal transit in healthy subjects: a randomized, placebo-controlled study.
    Park MI; Ferber I; Camilleri M; Allenby K; Trillo R; Burton D; Zinsmeister AR
    Neurogastroenterol Motil; 2006 Jan; 18(1):28-36. PubMed ID: 16371080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteers.
    Emmanuel AV; Kamm MA; Roy AJ; Antonelli K
    Gut; 1998 Apr; 42(4):511-6. PubMed ID: 9616313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of NGM282, an FGF19 variant, on colonic transit and bowel function in functional constipation: a randomized phase 2 trial.
    Oduyebo I; Camilleri M; Nelson AD; Khemani D; Nord SL; Busciglio I; Burton D; Rhoten D; Ryks M; Carlson P; Donato L; Lueke A; Kim K; Rossi SJ; Zinsmeister AR
    Am J Gastroenterol; 2018 May; 113(5):725-734. PubMed ID: 29717197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation.
    Wong BS; Camilleri M; McKinzie S; Burton D; Graffner H; Zinsmeister AR
    Am J Gastroenterol; 2011 Dec; 106(12):2154-64. PubMed ID: 21876564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of renzapride on transit in constipation-predominant irritable bowel syndrome.
    Camilleri M; McKinzie S; Fox J; Foxx-Orenstein A; Burton D; Thomforde G; Baxter K; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2004 Oct; 2(10):895-904. PubMed ID: 15476153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder.
    Bouras EP; Camilleri M; Burton DD; Thomforde G; McKinzie S; Zinsmeister AR
    Gastroenterology; 2001 Feb; 120(2):354-60. PubMed ID: 11159875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.